603939 益丰药房
2026/09 - 九个月
人民幣(K¥)
与去年同期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
营业总收入18,235,7055.49%24,433,16524,062,15522,588,22719,886,396
减:营业总成本16,277,4234.13%22,129,13421,973,89320,616,59718,008,275
    其中:营业成本10,988,2766.67%14,817,33014,408,31113,957,59912,025,564
               财务费用82,477-27.03%142,063173,90386,185104,812
               资产减值损失(69,734)-2.67%(111,612)(102,396)(72,634)(56,019)
公允价值变动收益------------
投资收益81,810-18.00%124,748108,12942,3726,869
    其中:对联营企业和合营企业的投资收益------(1)317(11)
营业利润2,039,93214.17%2,453,7242,203,8242,054,7851,885,533
利润总额2,025,75314.45%2,456,3952,182,4472,037,5941,877,487
减:所得税费用504,45114.80%625,369529,665456,663454,061
净利润1,521,30114.34%1,831,0261,652,7821,580,9311,423,426
减:非控股权益159,49165.09%152,544124,206168,946161,585
股东净利润1,361,81010.36%1,678,4821,528,5771,411,9851,261,841

市场价值指针
每股收益 (元) *1.1209.80%1.3801.2601.1701.260
每股派息 (元) *0.3000.00%0.7000.6500.5000.400
每股净资产 (元) *9.7818.24%9.4138.6649.70211.855
审计意见 #--标准无保留意见标准无保留意见标准无保留意见标准无保留意见
回页顶
备注: *未调整数据
#只提供简体内容